Status:
UNKNOWN
Characterization of Bleeding Disorders in EDS
Lead Sponsor:
University Health Network, Toronto
Conditions:
Ehlers-Danlos Syndrome
EDS
Eligibility:
All Genders
18+ years
Brief Summary
Ehlers-Danlos Syndrome (EDS) is a disease that weakens the connective tissues (i.e. tendons and ligaments) in the human body. EDS can make the joints loose and alter skin and wound healing. It can als...
Eligibility Criteria
Inclusion
- Any adult (≥ 18 years) patient with a known diagnosis of Ehlers Danlos Syndrome (Subtypes Classical, Hypermobile, or Vascular) as per the 2017 International Classification of Ehlers Danlos Syndrome.
Exclusion
- Subtypes of Ehlers Danlos Syndrome which are not Classical, Hypermobile, or Vascular.
- Unable or unwilling to consent for the study
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05434728
Start Date
November 1 2022
End Date
February 1 2024
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GoodHope EDS - Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4